2026 MBA Summer Internship of Lilly China Leadership Development Program at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Enrolled in an MBA program
Graduate by August 2027
Authorized to take internship job in China
Internship period: Mid of Jun, 2026 to end of Aug, 2026 (10 weeks)
Language fluency in Mandarin & English (both written and verbal)
Demonstrated leadership
Previous pharmaceutical or healthcare experience (preferred)
Commercialization experience (preferred)
Strong problem solving skills
Teamwork and collaboration abilities
Strong resilience
Flexibility and adaptability
Strong learning agility

Responsibilities

Commit to an initial assignment in country of origin (China) to learn the industry and understand customers (patients, payers, and providers)
Leverage and develop leadership skills in home affiliate as part of a global culture dedicated to employee development
Take on challenging assignments in Marketing, Finance, or Tech to help deliver experiences to customers (for Marketing MBAs specifically, promote development of leadership skills to lead a team within Lilly’s International Business Unit)

Skills

Key technologies and capabilities for this role

MBAMarketingFinanceTechnologyLeadershipBusiness Strategy

Questions & Answers

Common questions about this position

What are the basic qualifications for this MBA summer internship?

Candidates must be enrolled in an MBA program, graduate by August 2027, and be authorized to take the internship job in China.

What is the duration and timing of the internship?

The internship runs for 10 weeks from mid-June 2026 to the end of August 2026.

What additional skills or preferences are there for applicants?

Preferred skills include demonstrated leadership, previous pharmaceutical or healthcare experience, commercialization experience, strong problem-solving, teamwork, resilience, flexibility, adaptability, learning agility, and fluency in Mandarin and English.

What is the initial work location for this internship?

Interns are committed to an initial assignment in their country of origin, specifically authorized for work in China.

What kind of candidates is Lilly looking for in this program?

Lilly seeks highly motivated and driven leaders with integrity, excellence, respect for people, and a desire to make a difference in others' lives.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free